Blood markers in progressive multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at certain proteins in the blood of people with progressive MS to see if they can predict how the disease will progress. It may help doctors understand and manage the condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of multiple sclerosis (MS)
- You must have the progressive type of MS
- You must be between 18 and 60 years old
- You must have an EDSS score of 5.5 or higher, meaning you have significant walking difficulty
- You must not have had a relapse or changed your MS medication in the last 3 months
- You must not have any other neurological disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for signs of “synapse damage” in multiple sclerosis using blood tests and brain imaging (MRI). The goal is to find biomarkers that may help better understand MS and how it changes over time.
This study follows people with multiple sclerosis (MS) to see how the disease progresses over time. By tracking your health, researchers hope to learn more about MS and improve care.
This study looks at genetic information and blood test signals to understand why some people with early MS develop a worse outcome. It may help doctors predict who is at higher risk and better understand disease mechanisms.
This study measures blood markers (from a serum blood sample) to see how nerve and brain changes relate to MS disease activity and disability over time. It may help researchers better monitor MS, especially in people followed in the OFSEP program.
This study looks at how “iron rims” in brain MRI scans change over time in people with multiple sclerosis (MS). It may help researchers understand MS activity better and how iron changes relate to disease progression.
This study follows adults with relapsing-remitting multiple sclerosis using MRI scans and blood tests. It aims to understand how the disease behaves and what markers in blood and imaging may relate to changes over time.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.